Literature DB >> 33231054

Recommendations for the initial management of multisystem inflammatory syndrome temporally related to COVID-19, in children and adolescents.

Guillermo Kohn-Loncarica1, Ana Fustiñana2, Franco Díaz-Rubio3, Juan C Jaramillo-Bustamante4, Sebastián González-Dambrauskas5, Pablo Vásquez-Hoyos6, Jaime Fernández-Sarmiento7, Gustavo González8, Alejandro Mansur9, Javier Ponce10, Roberto Jabornisky11.   

Abstract

Multisystem inflammatory syndrome temporally related to COVID-19 in children and adolescents is a clinical presentation of SARS-CoV-2 infection. It shares some features with Kawasaki disease, toxic shock, sepsis, macrophage activation syndrome, and myocarditis. Few publications have addressed its initial management, which is similar to that proposed for septic shock. This review analyzes such approach based on the characteristics typical of multisystem inflammatory syndrome related to COVID-19 in accordance with the paradigm of an "institutional practice guideline" and suggests therapeutic approach strategies, including early detection, stabilization, referral, specific treatment, and process analysis. Sociedad Argentina de Pediatría.

Entities:  

Keywords:  COVID-19; SARSCoV-2; multisystem inflammatory syndrome; patient care bundles; sepsis

Mesh:

Year:  2020        PMID: 33231054     DOI: 10.5546/aap.2020.eng.e514

Source DB:  PubMed          Journal:  Arch Argent Pediatr        ISSN: 0325-0075            Impact factor:   0.635


  2 in total

Review 1.  Oral manifestations of multisystemic inflammatory syndrome in children (MIS-C) and Kawasaki disease associated to COVID-19: A systematic review.

Authors:  Rebeca Barros Nascimento; Nara Santos Araujo; Jamerson Carvalho Silva; Flávia Caló Aquino Xavier
Journal:  Spec Care Dentist       Date:  2021-11-18

2.  Late-Onset COVID-19-Related Multi-System Inflammatory Syndrome in a Middle-Aged Man.

Authors:  Zubaida Al-Falahi; Salma Al-Harthi; Hatem Farhan; Ibrahim Al Busaidi; Abdullah M Al Alawi
Journal:  Cureus       Date:  2021-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.